Concord Biotech Ltd
BSE:543960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concord Biotech Ltd
BSE:543960
|
IN |
|
NHPC Ltd
BSE:533098
|
IN |
|
M
|
Mike the Pike Productions Inc
OTC:MIKP
|
US |
|
York Water Co
NASDAQ:YORW
|
US |
|
Burberry Group PLC
LSE:BRBY
|
UK |
|
ADVFN PLC
LSE:AFN
|
UK |
|
Arlo Technologies Inc
NYSE:ARLO
|
US |
|
Crescent Point Energy Corp
TSX:CPG
|
CA |
|
V
|
Vindhya Telelinks Ltd
NSE:VINDHYATEL
|
IN |
|
G
|
Grounded People Apparel Inc
F:K1G
|
CA |
|
C
|
Clean Energy Fuels Corp
XMUN:WIQ
|
US |
|
P
|
Pacific Industrial Co Ltd
TSE:7250
|
JP |
|
Magna International Inc
TSX:MG
|
CA |
|
C
|
Clorox Co
SWB:CXX
|
US |
|
Teekay Corp
NYSE:TK
|
BM |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
|
GL Events SA
PAR:GLO
|
FR |
|
Patria Latin American Opportunity Acquisition Corp
NASDAQ:PLAO
|
KY |
|
Vestas Wind Systems A/S
CSE:VWS
|
DK |
|
National Storage Reit
ASX:NSR
|
AU |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
|
Tower Bersama Infrastructure Tbk PT
IDX:TBIG
|
ID |
Wall St Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 197.42 INR with a low forecast of 1 044.08 INR and a high forecast of 1 356.79 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 197.42
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 197.42 INR with a low forecast of 1 044.08 INR and a high forecast of 1 356.79 INR.
What is the Revenue forecast for Concord Biotech Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 14%.
What is the Gross Profit forecast for Concord Biotech Ltd?
Projected CAGR
19%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Concord Biotech Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Pre-Tax Income forecast for Concord Biotech Ltd?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Concord Biotech Ltd?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 13%.
